Scottish Centre for Infection and Environmental Health. Surveillance of known hepatitis C antibody positive cases in Scotland: results to December 31, 1997. SCIEH Weekly Report1999; 33: 190–96.
2.
WyldRRobertsonJ RBrettleRPAbsence of hepatitis C transmission but frequent transmission of HIV-1 from sexual contacts of doubly infected individuals. Journal of Infection1997; 35: 163–166.
3.
The Scottish Executive Health Department. 1998Health in Scotland. Edinburgh: The Stationery Office p 137–38.
4.
TaylorAGoldbergDHutchinsonSPrevalence of Hepatitis C virus infection among injecting drug users in Glasgow 1990–1996: are current harm reduction strategies working?Journal of Infection2000; 40: 176–183.
5.
GoreS MBirdA GCameronS OHutchinsonS JBurnsS MGoldbergD J. Prevalence of Hepatitis C carriage in Scottish prisons: Willing Anonymous Salivary hepatitis C (WASH-C) surveillance linked to self-reported risk behaviour. Quarterly Journal of Medicine1999; 92: 25–32.
6.
Scottish Affairs Committee: Drug Abuse in Scotland. House of Commons April 1994.
7.
GoreS MBrettleR PBurnsS MLewisS C. Pilot study to estimate survivors to 1995 of 1983–84 prevalent Hepatitis C infections in Lothian patients who tested positive or negative for Hepatitis B surface antigen in 1983-84. Journal of Infection1998; 37: 159–165.
8.
FrischerMGoldbergDTaylorABloorM. Estimating the Incidence and Prevalence of Injecting Drug Use in Glasgow. Addiction Research1997; 5 (4): 307–315.
9.
GoldbergDDavisBAllardiceGMcMenaminJCodereG. Monitoring the spread of HIV and AIDS in Scotland 1983–1994. Scot Med J1996; 41; 131–38.
10.
GoldbergDMcMenaminJ. The United Kingdom's Hepatitis B immunisation strategy — where now?Communicable Disease and Public Health1998; (2): 79–83.
11.
GoldbergDCameronSMcMenaminJ. Hepatitis C virus antibody prevalence among injecting drug users in Glasgow has fallen but remains high. Communicable Disease and Public Health1998; 1 (2): 95–97.
12.
StimsonG. AIDS and injecting drug use in the United Kingdom 1987–1993: the policy response and the prevention of the epidemic. Soc Sci Med1995; 41: 699–716.
13.
GruerLCameronJElliottL. Building a city wide service for exchanging needles and syringes. Br Med J1993; 306: 1394–97.
14.
GruerLWilsonPScottRGeneral practitioner centred scheme for treatment of opiate dependent drug injectors in Glasgow. Br Med J1997; 314: 1730–35.
15.
BrettleR P. HIV and harm reduction for injection drug users. AIDS1991; 5: 125–136.
16.
FrischerMBloorMGreenSGoldbergDMcKeganeyNCovellRTaylorA. Reduction in needle sharing among a community wide sample of injecting drug users. International Journal of STD and AIDS1992;3: 288–290.
17.
BathG EBurnsSDaviesA GDominyNPetersARichardsonA M. HIV prevalence in injecting drug users in Edinburgh. Fewer drug users share needles. Br Med J1993; 306: 1414.
18.
TaylorAGoldbergDEmslieJOutbreak of HIV infection in a Scottish prison. Br Med J1995; 310: 289–292.
19.
Information and Statistics Division of the Common Services Agency, National Health Service in Scotland. Drug Misuse Statistics, Scotland1998 Bulletin.
20.
SCIEH Weekly Report. Hepatitis B in Grampian1999; 33 (99/05): 49.
21.
HollingerF B. Hepatitis B Virus in Fields Virology. Edited by FieldsNBLippercroft-Raven Publishers, Philadelphia1996.
22.
Centers for Disease Control and Prevention. Recommendations for prevention and control of Hepatitis C virus (HCV) infection and HCV-related chronic disease. Morbidity and Mortality Weekly Report 1998; 47 (No RRO19).
23.
DelahookeTESHayesPC. Are cirrhosis and its complications inevitable in hepatitis C virus infection?Scot Med J2000; 45: 35–37.
24.
DavidGEsteban-MuirRRustgiVRecombinant interferon alfa-2b alone or in combination with ribavirin for retreatment of relapse of chronic hepatitis C. New England Journal of Medicine339: 1493–99.
25.
HutchinsonSTaylorAGoldbergDGruerL. Factors associated with injecting risk behaviour among serial community-wide samples of injecting drug users in Glasgow 1990–94: implications for control and prevention of bloodborne viruses. Addiction2000; 95 (6): 931–941.
26.
HeptonstallJ. Surgeons who test positive for hepatitis C should be transferred to low risk duties. Rev. Med. Virol.2000; 10: 75–78.